Regulators, developers, and testing laboratories are exploring in silico models, transporter assays, and other options to better predict drug combination outcomes In the future, many drug–drug ...
Aim: Drug–drug interactions (DDIs) are a widely recognized major cause of adverse drug reactions, but two other newly described important types of interactions also exist: drug–gene interactions (DGIs ...
ZURICH, SWITZERLAND / ACCESSWIRE / June 14, 2023 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and ...
The most common manifestation of pharmacokinetic interactions with warfarin involves the inhibition or induction of its metabolism. Attention should be paid to the relative importance of the warfarin ...
Iam not an expert in managed care.Instead, I have spent a considerableamount of time trying to understanddrug—drug interactions (DDIs) in terms ofthe mechanisms underlying such interactions,the way ...
Xenobiotics are drugs and environmental toxins, which usually enter the body via the skin, lung, or stomach and may be toxic if they accumulate in large amounts. For example, the painkiller ...
LONDON, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company developing novel inhaled therapies for patients suffering from serious acute and ...
Very low risk for drug-drug interactions (DDI) with Mazindol ER based upon results from in vitro metabolism and transporter studies Demonstrated pharmacological differentiation versus currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results